Quartic.ai and Bright Path Labs announced today that they’ve agreed to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients (APIs) and other small molecule drugs. The technology will use Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology. The companies are touting the technology as a way to diversify supplies of APIs, many…